Search research articles
Contact Us
Filters
Showing results (11-20 of 69) with videos related to
Page
of 7
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 29, 2005
Effects of finasteride (1 mg) on hair transplant
Matt Leavitt, David Perez-Meza, Naveen A Rao, et al.
Cardiovascular Diabetology
|
January 5, 2013
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
Samuel S Engel, Gregory T Golm, Deborah Shapiro, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 25, 2015
Erratum to: Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials
Elizabeth S Ommen, Lei Xu, Edward A O'Neill, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 31, 2015
Comparison of treatment with sitagliptin or sulfonylurea in patients with type 2 diabetes mellitus and mild renal impairment: a post hoc analysis of clinical trials
Elizabeth S Ommen, Lei Xu, Edward A O'Neill, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
August 28, 2020
Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency
Annaswamy Raji, Zhi Jin Xu, Raymond L H Lam, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 13, 2013
Assessment of AACE/ACE recommendations for initial dual antihyperglycemic therapy using the fixed-dose combination of sitagliptin and metformin versus metformin
Samuel S Engel, Thomas L Seck, Gregory T Golm, et al.
Drugs & Aging
|
February 11, 2014
Safety of sitagliptin in elderly patients with type 2 diabetes: a pooled analysis of 25 clinical studies
Elizabeth M Round, Samuel S Engel, Gregory T Golm, et al.
European Journal of Dermatology : EJD
|
June 25, 2008
Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients
Keith D Kaufman, Cynthia J Girman, Elizabeth M Round, et al.
Diabetes, Obesity & Metabolism
|
April 28, 2017
A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes
Ira Gantz, Taro Okamoto, Yuka Ito, et al.
Current Medical Research and Opinion
|
February 24, 2009
Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study
Debora Williams-Herman, Jeremy Johnson, Rujun Teng, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 69) with videos related to
Sort By:
Page
of 7
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 29, 2005
Effects of finasteride (1 mg) on hair transplant
Matt Leavitt, David Perez-Meza, Naveen A Rao, et al.
Cardiovascular Diabetology
|
January 5, 2013
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
Samuel S Engel, Gregory T Golm, Deborah Shapiro, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 25, 2015
Erratum to: Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials
Elizabeth S Ommen, Lei Xu, Edward A O'Neill, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 31, 2015
Comparison of treatment with sitagliptin or sulfonylurea in patients with type 2 diabetes mellitus and mild renal impairment: a post hoc analysis of clinical trials
Elizabeth S Ommen, Lei Xu, Edward A O'Neill, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
August 28, 2020
Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency
Annaswamy Raji, Zhi Jin Xu, Raymond L H Lam, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 13, 2013
Assessment of AACE/ACE recommendations for initial dual antihyperglycemic therapy using the fixed-dose combination of sitagliptin and metformin versus metformin
Samuel S Engel, Thomas L Seck, Gregory T Golm, et al.
Drugs & Aging
|
February 11, 2014
Safety of sitagliptin in elderly patients with type 2 diabetes: a pooled analysis of 25 clinical studies
Elizabeth M Round, Samuel S Engel, Gregory T Golm, et al.
European Journal of Dermatology : EJD
|
June 25, 2008
Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients
Keith D Kaufman, Cynthia J Girman, Elizabeth M Round, et al.
Diabetes, Obesity & Metabolism
|
April 28, 2017
A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes
Ira Gantz, Taro Okamoto, Yuka Ito, et al.
Current Medical Research and Opinion
|
February 24, 2009
Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study
Debora Williams-Herman, Jeremy Johnson, Rujun Teng, et al.
Page
of 7